BioSpace News Archive

For the first time since 1949, outbound transportation from a provincial capital in China is being shut down, in response to an outbreak of a novel coronavirus infection, reports the Washington Post, in the middle of the busiest travel season of the year.

To date, there have been 830 confirmed cases and 26 deaths - all but two of the fatalities have been in Wuhan and most have been elderly

The Washington Area Hyundai Dealers, The Washington Auto Show, Georgetown Lombardi Comprehensive Cancer Center, and Children’s National Hospital are teaming up to help fight pediatric cancer through the Hyundai Hands On Hope Contest at the 2020 Washington Auto Show.

Pharmaceutical Executive®, a multimedia platform for industry leaders to exchange experiences and insights about innovative business and marketing ideas, is now accepting nominations for the 2020 Emerging Pharma Leaders awards program, which recognizes and honors up-and-coming professionals who are vital to the future of the pharmaceutical and biotech industries

Unprofessional physician behaviors can result in serious consequences including decreased physician and staff productivity, increased staff turnover and adverse patient outcomes

AI platform was developed at the Ray and Stephanie Lane Center for Computational Biology, which became the Computational Biology Department at Carnegie Mellon University and was successfully tested by several pharma companies

Koneksa Health, the leader in developing and implementing patient-focused digital biomarkers for drug development, along with Merck & Co, Inc. (NYSE: MRK) announced the publication of a peer-reviewed Phase I clinical trial evaluating the accuracy and sensitivity of mobile health (mHealth) technologies to measure heart rate and blood pressure.

Oncopeptides AB (Nasdaq Stockholm: ONCO) announces today that it will host a webcast at 11am (CET) on Monday, January 27th 2020 where CEO Jakob Lindberg will present and explain melflufen’s mechanism of action.

Onco360®, the nation’s largest independent Oncology Pharmacy, has been selected by Epizyme to be the exclusive specialty pharmacy partner for TAZVERIK™ (Tazemetostat), a new oral treatment for adult and pediatric patients (aged 16 years and older) with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection.

In a follow-up to the landmark 2011 study that demonstrated prenatal surgery for spina bifida has measurable benefits over surgery after birth for one of the most disabling neural tube defects, researchers have published new findings.